Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

Rhea-AI Summary

Aadi Bioscience, Inc. (NASDAQ: AADI) will host a conference call and webcast on March 13, 2024, to report fourth quarter and full-year 2023 financial results and provide corporate updates.

Company to Host Conference Call and Webcast on March 13, 2024

LOS ANGELES, March 6, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway alterations, today announced that it will host a conference call and live webcast on Wednesday, March 13, 2024 at 8:30 am ET (5:30 am PT) to report fourth quarter and full-year 2023 financial results and provide recent corporate updates.

Conference Call Information 

Participants may access a live webcast of the call on the "Investors & News" page of the Aadi Bioscience website at aadibio.com. To participate via telephone, please register in advance here: Conference Registration (vevent.com). Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the website for at least 30 days.

About Aadi Bioscience, Inc.

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for cancers to bring transformational therapies to cancer patients with alterations in the mTOR pathway, a key regulator of cell growth and cancer progression. Aadi received FDA approval and has commercialized FYARRO^® for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

Aadi has also initiated PRECISION1, a Phase 2 tumor-agnostic registration-intended trial in mTOR inhibitor-naïve malignant solid tumors harboring TSC1 or TSC2 inactivating alterations. More information on the Company's development pipeline is available on the Aadi website at www.aadibio.com and connect with us on Twitter and LinkedIn.

Contact:
IR@aadibio.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-report-fourth-quarter-and-full-year-2023-results-and-corporate-update-302078967.html

SOURCE Aadi Bioscience

FAQ

When will Aadi Bioscience host a conference call and webcast?

Aadi Bioscience will host a conference call and webcast on March 13, 2024.

What is the ticker symbol for Aadi Bioscience?

The ticker symbol for Aadi Bioscience is AADI.

What will be discussed during the conference call and webcast?

The conference call will report fourth quarter and full-year 2023 financial results and provide recent corporate updates.

How can participants access the live webcast?

Participants can access the live webcast on the 'Investors & News' page of the Aadi Bioscience website at aadibio.com.

How can participants join via telephone?

Participants can register in advance on the Conference Registration page and will receive a confirmation email with details on how to join the call.